Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis".

Autor: Li K; Heilongjiang University of Chinese Medicine, Harbin, China., Xia X; Heilongjiang University of Chinese Medicine, Harbin, China., Fu T; Brandeis University, Waltham, MA, United States., Tong Y; Hospital, Heilongjiang University of Chinese Medicine, Harbin, China. Electronic address: tongying@hljucm.edu.cn.
Jazyk: angličtina
Zdroj: Pharmacological research [Pharmacol Res] 2024 Nov; Vol. 209, pp. 107329. Date of Electronic Publication: 2024 Aug 06.
DOI: 10.1016/j.phrs.2024.107329
Abstrakt: Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Databáze: MEDLINE
Externí odkaz: